user comprehension

23andMe Granted The First and Only FDA Authorization For Direct-to-Consumer Pharmacogenetics Reports

October 31, 2018
The U.S. Food and Drug Administration (FDA) granted 23andMe authorization to offer reports to customers on pharmacogenetics, indicating how customers’ genetics may influence the way they metabolize certain medications.
Read More